FDA Orange Book
Is there a generic for iDose TR?
iDose TR contains travoprost. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for iDose TR (travoprost). The Orange Book shows its last listed patent expires February 14, 2031 and its last listed exclusivity ends December 13, 2026.
Run it in Rivvi
Map iDose TR and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
iDose TR products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| implant, intracameral | 75MCG | Marketed (Rx) | None | 0 | None |
NDA 218010, held by GLAUKOS CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
iDose TR patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 12201557 | June 18, 2030 | Drug substance, Drug product | U-4129 | 218010 |
| 11426306 | October 17, 2030 | Drug product | None | 218010 |
| 10206813 | October 17, 2030 | Drug product | None | 218010 |
| 12201555 | February 14, 2031 | Drug substance, Drug product | None | 218010 |
iDose TR exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NP | New product | December 13, 2026 | 218010 |
iDose TR NDC codes
Questions
Is there a generic for iDose TR?
No. The Orange Book lists no active FDA-approved generic (ANDA) for iDose TR (travoprost). The Orange Book shows its last listed patent expires February 14, 2031 and its last listed exclusivity ends December 13, 2026.
What is the generic name for iDose TR?
The active ingredient in iDose TR is travoprost, per the FDA Orange Book.
When does the iDose TR patent expire?
The last patent listed for iDose TR in the Orange Book expires February 14, 2031. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.